Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Neostigmine for Recovery After Anterior Cervical Spine Surgery in Elderly Patients
NCT04161508Unknown
- Sponsor
- Taipei Veterans General Hospital
- Start
- Dec 2019
- Primary completion
- Dec 2021
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
Randomised, double-blind trial of Sugammadex in Residual neuromuscular blockade (RNMB), sponsored by Taipei Veterans General Hospital. Primary endpoint: Mean time to 90% Train-of-Four ratio at 2 hours. Status: unknown.
02
Drugs
Sugammadex
03
Conditions
Residual neuromuscular blockade (RNMB)
Beyond the preview
Go deeper on NCT04161508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04161508.